Overview

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
A Korean open-label, community-based trial assessing the efficacy and safety of levetiracetam as adjunctive therapy in partial epilepsy. Similarity with a similar study conducted in Caucasian epileptic subjects will be assessed.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam